These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1535677)

  • 1. Neutral endopeptidase inhibition increases the urinary excretion and plasma levels of endothelin.
    Abassi Z; Golomb E; Keiser HR
    Metabolism; 1992 Jul; 41(7):683-5. PubMed ID: 1535677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of neutral endopeptidase in the metabolism of endothelin.
    Abassi ZA; Tate JE; Golomb E; Keiser HR
    Hypertension; 1992 Jul; 20(1):89-95. PubMed ID: 1618556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the ECE/NEP inhibitor CGS 34225 on the big ET-1-induced pressor response and plasma atrial natriuretic peptide concentration in conscious rats.
    Trapani AJ; Beil ME; Bruseo CW; Fink CA; Hoyer D; Savage P; Jeng AY
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():102S-106S. PubMed ID: 12193065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal and depressor effects of SQ 29,072, a neutral endopeptidase inhibitor, in conscious hypertensive rats.
    Seymour AA; Norman JA; Asaad MM; Fennell SA; Swerdel JN; Little DK; Dorso CR
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):163-72. PubMed ID: 1696660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
    Kukkonen P; Vuolteenaho O; Ruskoaho H
    Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of the depressor responses to atrial natriuretic peptides in conscious SHR by an inhibitor of neutral endopeptidase.
    Seymour AA; Swerdel JN; Fennell SA; Druckman SP; Neubeck R; Delaney NG
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):194-204. PubMed ID: 2476591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive and renal activity of SQ 28,603, an inhibitor of neutral endopeptidase.
    Seymour AA; Norman JA; Asaad MM; Fennell SA; Little DK; Kratunis VJ; Rogers WL
    J Cardiovasc Pharmacol; 1991 Feb; 17(2):296-304. PubMed ID: 1709235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel neurohormonal modulators in cardiovascular disorders. The therapeutic potential of endopeptidase inhibitors.
    Kentsch M; Otter W
    Drugs R D; 1999 Apr; 1(4):331-8. PubMed ID: 10566056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
    Pham I; el Amrani AI; Fournié-Zaluski MC; Corvol P; Roques B; Michel JB
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CGS 34226, a thiol-based dual inhibitor of endothelin converting enzyme-1 and neutral endopeptidase 24.11.
    Jeng AY; Savage P; Beil ME; Bruseo CW; Hoyer D; Fink CA; Trapani AJ
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():98S-101S. PubMed ID: 12193064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of neutral endopeptidase inhibition on the clearance of exogenously administered endothelin in Sprague-Dawley rats.
    Asaad MM; Dorso CR; Moreland SM
    J Cardiovasc Pharmacol; 1993 Apr; 21(4):633-6. PubMed ID: 7681910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of endothelin-1 and big endothelin-1 by recombinant neutral endopeptidase EC.3.4.24.11.
    Abassi ZA; Golomb E; Bridenbaugh R; Keiser HR
    Br J Pharmacol; 1993 Aug; 109(4):1024-8. PubMed ID: 8401914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple vasopeptidase inhibition normalizes blood pressure in conscious, unrestrained, and spontaneously hypertensive rats.
    Daull P; Benrezzak O; Arsenault D; Pheng LH; Blouin A; Cayer J; Beaudoin M; Belleville K; Sirois P; Nantel F; Jeng AY; Battistini B
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1606-13. PubMed ID: 16364833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of renal effects of atrial natriuretic factor-(99-126) by SQ 29,072.
    Seymour AA; Fennell SA; Swerdel JN
    Hypertension; 1989 Jul; 14(1):87-97. PubMed ID: 2544529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cyclosporin A on the synthesis, excretion, and metabolism of endothelin in the rat.
    Abassi ZA; Pieruzzi F; Nakhoul F; Keiser HR
    Hypertension; 1996 May; 27(5):1140-8. PubMed ID: 8621208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of C-ANF receptor and neutral endopeptidase on pharmacokinetics of ANF in rats.
    Chiu PJ; Tetzloff G; Romano MT; Foster CJ; Sybertz EJ
    Am J Physiol; 1991 Jan; 260(1 Pt 2):R208-16. PubMed ID: 1847022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of kidney neutral endopeptidase after administration of the neutral endopeptidase inhibitor candoxatril: quantitation by autoradiography.
    Yoshida K; Kanazawa M; Casley DJ; Katopothis A; Johnston CI
    J Cardiovasc Pharmacol; 1998 Nov; 32(5):702-8. PubMed ID: 9821842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excretory responses to renal nerve stimulation during inhibition of neutral metalloendopeptidase and angiotensin-converting enzyme in the rat.
    Golin R; Protasoni G; Wjinmaalen P; Sala C; Monopoli A; Casati C; Zanchetti A; Stella A
    J Cardiovasc Pharmacol; 1996 Nov; 28(5):665-71. PubMed ID: 8945680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of ANP-dependent effects of endothelin by inhibitors of neutral endopeptidase and cGMP phosphodiesterase.
    Valentin JP; Qiu C; Wiedemann E; Gardner DG; Humphreys MH
    J Pharmacol Exp Ther; 1995 May; 273(2):744-52. PubMed ID: 7752077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
    Pham I; Gonzalez W; el Amrani AI; Fournié-Zaluski MC; Philippe M; Laboulandine I; Roques BP; Michel JB
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.